Samin-derived flavonolignans, a new series of antidiabetic agents having dual inhibition against α-glucosidase and free radicals.

  • PubMed
  • May 4, 2025
  • 0 Comments

Samin-derived flavonolignans, a new series of antidiabetic agents having dual inhibition against α-glucosidase and free radicals.

Autor: Worawalai, Wisuttaya; Phuwapraisirisan, Preecha

Publication year: 2020

Natural product research

issn:1478-6427 1478-6419

doi: 10.1080/14786419.2018.1553169


Abstract:

A series of novel flavonolignans were synthesized by the reaction between a lignan named samin (1) and a range of flavonoids. This simple and rapid approach allowed direct assembly of these two bulky motifs in good yields without the formation of byproducts. Upon evaluation of antidiabetic activity of the synthesized products, epicatechinosamin (β-2g) was the most active α-glucosidase inhibitor toward maltase and sucrase. The kinetic study indicated that β-2 g inhibited the enzymes in a mixed manner of competitive and noncompetitive inhibition.

Language: eng

Rights:

Pmid: 30618297

Tags: Kinetics; diabetes; Magnetic Resonance Spectroscopy; Molecular Structure; antioxidant; Flavonoids/chemistry; alpha-Glucosidases/metabolism; Antioxidants/chemistry/pharmacology; Flavonolignan; Flavonolignans/chemistry/*pharmacology; Free Radicals/metabolism; Friedel-Crafts; glucosidase; Glycoside Hydrolase Inhibitors/chemistry/*pharmacology; Hypoglycemic Agents/*chemistry/*pharmacology; oxocarbenium

Link: https://pubmed.ncbi.nlm.nih.gov/30618297/

  • Related Posts

    Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial

    Health Technol Assess. 2025 May;29(12):1-118. doi: 10.3310/YQVF5347. ABSTRACT BACKGROUND: Lithium and several atypical antipsychotics are the recommended first-line augmentation options for treatment-resistant depression; however, few studies have compared them directly,…

    Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial

    Health Technol Assess. 2025 May;29(12):1-118. doi: 10.3310/YQVF5347. ABSTRACT BACKGROUND: Lithium and several atypical antipsychotics are the recommended first-line augmentation options for treatment-resistant depression; however, few studies have compared them directly,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    • May 10, 2025
    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    • May 10, 2025
    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    • May 10, 2025
    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    • May 10, 2025
    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    • May 10, 2025
    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    How Microwaves Actually Work: A Scientific Breakdown

    • May 10, 2025
    How Microwaves Actually Work: A Scientific Breakdown